Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
| Molecular Weight | 225.20 g/mol |
|---|---|
| Molecular Formula | C8H11N5O3 |
| XLogP3 | -1.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 225.08618923 g/mol |
| Monoisotopic Mass | 225.08618923 g/mol |
| Topological Polar Surface Area | 115 A^2 |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 308 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 8 | |
|---|---|
| Drug Name | Acyclovir |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | ZOVIRAX is the brand name for acyclovir, a synthetic nucleoside analogue active against herpesviruses. ZOVIRAX Cream 5% is a formulation for topical administration. Each gram of ZOVIRAXCream 5% contains 50mg of acyclovir and the following inactiv... |
| Active Ingredient | Acyclovir |
| Dosage Form | Ointment; Tablet; Capsule; Suspension |
| Route | Topical; Oral |
| Strength | 5%; 200mg/5ml; 200mg; 800mg; 400mg |
| Market Status | Prescription |
| Company | Amneal Pharms; Mylan Pharms; Ranbaxy; Hetero Labs Ltd V; Hi Tech Pharma; Actavis Mid Atlantic; Teva; Cadila Pharms; Apotex; Zydus Pharms Usa; Carlsbad; Mylan; Stason; Dava Pharms |
| 2 of 8 | |
|---|---|
| Drug Name | Acyclovir sodium |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | Acyclovir is a synthetic nucleoside analog active against herpes viruses. Acyclovir for Injection USP is a sterile lyophilized powder for intravenous administration only. Each 500 mg vial contains 500 mg of acyclovir and 49 mg of sodium, and each 100... |
| Active Ingredient | Acyclovir sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 50mg base/ml; eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Bedford; Fresenius Kabi Usa; Aurobindo Pharma |
| 3 of 8 | |
|---|---|
| Drug Name | Sitavig |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | SITAVIG (acyclovir) buccal tablet is applied topically to the gum and releases acyclovir as the buccal tablet gradually dissolves [see ClinicalPharmacology (12.3)]. Acyclovir is a synthetic purine nucleoside analogue active against herpes viruses. Th... |
| Active Ingredient | Acyclovir |
| Dosage Form | Tablet |
| Route | Buccal |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Innocutis Holdings |
| 4 of 8 | |
|---|---|
| Drug Name | Zovirax |
| Drug Label | ZOVIRAX is the brand name for acyclovir, a synthetic nucleoside analogue active against herpesviruses. ZOVIRAX Cream 5% is a formulation for topical administration. Each gram of ZOVIRAXCream 5% contains 50mg of acyclovir and the following inactiv... |
| Active Ingredient | Acyclovir |
| Dosage Form | Ointment; Tablet; Cream; Capsule; Suspension |
| Route | Oral; Topical |
| Strength | 200mg/5ml; 200mg; 800mg; 400mg; 5% |
| Market Status | Prescription |
| Company | Delcor Asset; Valeant Bermuda |
| 5 of 8 | |
|---|---|
| Drug Name | Acyclovir |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | ZOVIRAX is the brand name for acyclovir, a synthetic nucleoside analogue active against herpesviruses. ZOVIRAX Cream 5% is a formulation for topical administration. Each gram of ZOVIRAXCream 5% contains 50mg of acyclovir and the following inactiv... |
| Active Ingredient | Acyclovir |
| Dosage Form | Ointment; Tablet; Capsule; Suspension |
| Route | Topical; Oral |
| Strength | 5%; 200mg/5ml; 200mg; 800mg; 400mg |
| Market Status | Prescription |
| Company | Amneal Pharms; Mylan Pharms; Ranbaxy; Hetero Labs Ltd V; Hi Tech Pharma; Actavis Mid Atlantic; Teva; Cadila Pharms; Apotex; Zydus Pharms Usa; Carlsbad; Mylan; Stason; Dava Pharms |
| 6 of 8 | |
|---|---|
| Drug Name | Acyclovir sodium |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | Acyclovir is a synthetic nucleoside analog active against herpes viruses. Acyclovir for Injection USP is a sterile lyophilized powder for intravenous administration only. Each 500 mg vial contains 500 mg of acyclovir and 49 mg of sodium, and each 100... |
| Active Ingredient | Acyclovir sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 50mg base/ml; eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Bedford; Fresenius Kabi Usa; Aurobindo Pharma |
| 7 of 8 | |
|---|---|
| Drug Name | Sitavig |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | SITAVIG (acyclovir) buccal tablet is applied topically to the gum and releases acyclovir as the buccal tablet gradually dissolves [see ClinicalPharmacology (12.3)]. Acyclovir is a synthetic purine nucleoside analogue active against herpes viruses. Th... |
| Active Ingredient | Acyclovir |
| Dosage Form | Tablet |
| Route | Buccal |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Innocutis Holdings |
| 8 of 8 | |
|---|---|
| Drug Name | Zovirax |
| Drug Label | ZOVIRAX is the brand name for acyclovir, a synthetic nucleoside analogue active against herpesviruses. ZOVIRAX Cream 5% is a formulation for topical administration. Each gram of ZOVIRAXCream 5% contains 50mg of acyclovir and the following inactiv... |
| Active Ingredient | Acyclovir |
| Dosage Form | Ointment; Tablet; Cream; Capsule; Suspension |
| Route | Oral; Topical |
| Strength | 200mg/5ml; 200mg; 800mg; 400mg; 5% |
| Market Status | Prescription |
| Company | Delcor Asset; Valeant Bermuda |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CAPSULE;ORAL - 200MG **Federal Regis...DOSAGE - CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 18828
DOSAGE - SUSPENSION;ORAL - 200MG/5ML
USFDA APPLICATION NUMBER - 19909
DOSAGE - TABLET;ORAL - 400MG **Federal Regist...DOSAGE - TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20089
DOSAGE - TABLET;ORAL - 800MG **Federal Regist...DOSAGE - TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20089
DOSAGE - CREAM;TOPICAL - 5%;1%
USFDA APPLICATION NUMBER - 22436
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Disintegrants & Superdisintegrants
Thickeners and Stabilizers
Direct Compression
Granulation
Topical
Coating Systems & Additives
Solubilizers
Film Formers & Plasticizers
Controlled & Modified Release
Lubricants & Glidants
Co-Processed Excipients
Taste Masking
Parenteral
Chewable & Orodispersible Aids
Empty Capsules
Emulsifying Agents
Rheology Modifiers
Coloring Agents
Surfactant & Foaming Agents
Soft Gelatin
API Stability Enhancers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
ABOUT THIS PAGE
59
PharmaCompass offers a list of Aciclovir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aciclovir manufacturer or Aciclovir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aciclovir manufacturer or Aciclovir supplier.
PharmaCompass also assists you with knowing the Aciclovir API Price utilized in the formulation of products. Aciclovir API Price is not always fixed or binding as the Aciclovir Price is obtained through a variety of data sources. The Aciclovir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Acyclovir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acyclovir, including repackagers and relabelers. The FDA regulates Acyclovir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acyclovir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Acyclovir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Acyclovir supplier is an individual or a company that provides Acyclovir active pharmaceutical ingredient (API) or Acyclovir finished formulations upon request. The Acyclovir suppliers may include Acyclovir API manufacturers, exporters, distributors and traders.
click here to find a list of Acyclovir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Acyclovir DMF (Drug Master File) is a document detailing the whole manufacturing process of Acyclovir active pharmaceutical ingredient (API) in detail. Different forms of Acyclovir DMFs exist exist since differing nations have different regulations, such as Acyclovir USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Acyclovir DMF submitted to regulatory agencies in the US is known as a USDMF. Acyclovir USDMF includes data on Acyclovir's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Acyclovir USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Acyclovir suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Acyclovir Drug Master File in Japan (Acyclovir JDMF) empowers Acyclovir API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Acyclovir JDMF during the approval evaluation for pharmaceutical products. At the time of Acyclovir JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Acyclovir suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Acyclovir Drug Master File in Korea (Acyclovir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Acyclovir. The MFDS reviews the Acyclovir KDMF as part of the drug registration process and uses the information provided in the Acyclovir KDMF to evaluate the safety and efficacy of the drug.
After submitting a Acyclovir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Acyclovir API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Acyclovir suppliers with KDMF on PharmaCompass.
A Acyclovir CEP of the European Pharmacopoeia monograph is often referred to as a Acyclovir Certificate of Suitability (COS). The purpose of a Acyclovir CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Acyclovir EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Acyclovir to their clients by showing that a Acyclovir CEP has been issued for it. The manufacturer submits a Acyclovir CEP (COS) as part of the market authorization procedure, and it takes on the role of a Acyclovir CEP holder for the record. Additionally, the data presented in the Acyclovir CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Acyclovir DMF.
A Acyclovir CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Acyclovir CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Acyclovir suppliers with CEP (COS) on PharmaCompass.
A Acyclovir written confirmation (Acyclovir WC) is an official document issued by a regulatory agency to a Acyclovir manufacturer, verifying that the manufacturing facility of a Acyclovir active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Acyclovir APIs or Acyclovir finished pharmaceutical products to another nation, regulatory agencies frequently require a Acyclovir WC (written confirmation) as part of the regulatory process.
click here to find a list of Acyclovir suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Acyclovir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Acyclovir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Acyclovir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Acyclovir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Acyclovir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Acyclovir suppliers with NDC on PharmaCompass.
Acyclovir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acyclovir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acyclovir GMP manufacturer or Acyclovir GMP API supplier for your needs.
A Acyclovir CoA (Certificate of Analysis) is a formal document that attests to Acyclovir's compliance with Acyclovir specifications and serves as a tool for batch-level quality control.
Acyclovir CoA mostly includes findings from lab analyses of a specific batch. For each Acyclovir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acyclovir may be tested according to a variety of international standards, such as European Pharmacopoeia (Acyclovir EP), Acyclovir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acyclovir USP).
